BIOQUÍMICA Y BIOLOGÍA MOLECULAR III E INMUNOLOGÍA
Departamento
Universidad de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Navarra (9)
2023
-
Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi
Molecular Therapy Nucleic Acids, Vol. 34
-
Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)
Bone Marrow Transplantation
2022
-
Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer
Pharmaceutics, Vol. 14, Núm. 3
2021
2013
-
Allelic variants in TLR10 gene may influence bilateral affectation and clinical course of Meniere's disease
Immunogenetics, Vol. 65, Núm. 5, pp. 345-355
2010
-
SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia
Blood, Vol. 115, Núm. 3, pp. 615-625
2009
-
Efficient recovery of HLA class i expression in human tumor cells after beta2-microglobulin gene transfer using adenoviral vector: Implications for cancer immunotherapy
Scandinavian Journal of Immunology, Vol. 70, Núm. 2, pp. 125-135
-
Total HLA class I loss in a human melanoma cell line: identification of a mutation in beta2-microglobulin gene and its correction using adenoviral vector (ADCMVbeta2M)
TISSUE ANTIGENS